Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05676619
Other study ID # 0865
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 16, 2023
Est. completion date April 14, 2024

Study information

Verified date May 2023
Source University of Leicester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will carry out a proof-of-concept study in 20 adult healthy male and female volunteers in order to: assess a 3D foot scanner's reliability. Specifically, the investigators will assess its variability during repeated foot scans of the same subject's foot. Three repeated foot scans will be carried out by two different examiners to measure intrarater and interrater reliability (Intraclass Correlation Coefficient


Description:

Evidence of reliability is essential for use of a 3D foot scanner in diabetes footwear fit evaluation and orthopaedic footwear design. The investigators will carry out a proof-of-concept study in 20 healthy adult male and female volunteers in order to: assess the 3D foot scanner's reliability. Specifically, the investigators will assess its variability during three repeated foot scans of the same subject's foot. Three half weightbearing foot scans will be carried out by two different examiners to measure intrarater and interrater reliability (Intraclass Correlation Coefficient). The investigators will carry out a proof-of-concept study in 20 healthy adult male and female volunteers (10 each) in order to assess the Elinvision 3D foot scanner's (i) intra-rater reliability through repeated foot scans (3 times each) and (ii) inter-rater reliability of these scans as carried out by two independent examiners whilst participants are half weightbearing to establish adequate reliability (0.80+ ICC) for use in subsequent diabetes footwear fit assessment and orthopaedic footwear design and manufacture.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date April 14, 2024
Est. primary completion date April 14, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Healthy men and women aged 18 years or over - Able to walk unaided - Able to walk up steps (the 3D scanner requires a small step on to the device to enter the correct position for measurement) - Willingness and capacity to participate in the study and to sign the informed consent form Exclusion Criteria: - Diabetes mellitus diagnosis - Inability to ambulate independently without walking aids - No obvious foot deformities - No history of foot surgery - No pain, injuries or medical conditions affecting the legs or lower back - Any issues around balance (participants must remain standing in position for the approximately fifteen seconds required to obtain the 3D scan of their feet) - Health conditions that impact foot morphology

Study Design


Related Conditions & MeSH terms


Intervention

Device:
3D foot scanner
Reliability of 3D foot scanner during repeated scans

Locations

Country Name City State
United Kingdom Leicester General Hospital Leicester

Sponsors (2)

Lead Sponsor Collaborator
University of Leicester University Hospitals, Leicester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intrarater reliability (Intraclass Correlation Coefficient) of 3D foot scans repeated at baseline (change) (i) Intrarater reliability (Intraclass Correlation Coefficient) based on three scans of the same subject's foot whilst half-weightbearing carried out by the same 'rater' i.e. person using the 3D foot scanner; Repeated scans at baseline
Primary Interrater reliability (Intraclass Correlation Coefficient) of 3D foot scans repeated at baseline (change) (ii) Interrater reliability (Intraclass Correlation Coefficient) based on three scans of the same subject's foot first by one rater (as above) and then by a second rater Repeated scans at baseline
See also
  Status Clinical Trial Phase
Recruiting NCT03022721 - Heidelberg Study on Diabetes and Complications N/A
Withdrawn NCT02580266 - Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes
Completed NCT02423434 - Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
Completed NCT03426566 - Abnormal Plantar Pressure in Patients With Diabetes
Completed NCT01695278 - A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community Phase 3
Completed NCT02588898 - B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes
Completed NCT00815178 - Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle Weakness N/A
Not yet recruiting NCT04537676 - Patient Empowerment Study
Terminated NCT02915263 - The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes Phase 2
Completed NCT01929018 - Collaborative-care Rehabilitation After Dysvascular Amputation N/A
Completed NCT03877523 - Cocarnit Effects on Macrophages Polarization N/A
Completed NCT02928939 - Therapeutic Conflicts and Multimorbidity
Completed NCT02947828 - Polyneuropathy in Diabetes Mellitus Type 2
Recruiting NCT02275091 - Children With Diabetes at Risk for Heart Disease.
Terminated NCT00529204 - Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease Phase 2
Not yet recruiting NCT05074849 - Benefits of Insoles With Real-Time Alert and Foot Self-Care Education N/A
Completed NCT04963998 - Safety and Efficacy Study of MedCu Wound Dressings N/A
Recruiting NCT06321029 - Electronic Diabetes Tune-Up Group (eDTU) for African Americans N/A
Active, not recruiting NCT03620773 - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes Phase 1/Phase 2
Completed NCT05231642 - Individualised Postprandial Glucose Responses in Type 1 Diabetes N/A